Stories about Astrazeneca Plc
From Benzinga
Which COVID-19 vaccine should I take?
February 26, 2021
From MarketWatch
The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
February 26, 2021
From Benzinga
Johnson & Johnson's COVID-19 Vaccine Likely To Get EU Approval Early March: Bloomberg
February 26, 2021
From Benzinga
Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning
February 26, 2021
Benzinga's Top Ratings Upgrades, Downgrades For February 25, 2021
February 25, 2021
From Benzinga
Moderna Raises 2021 Base COVID-19 Vaccine Production Plan To 700M Doses
February 25, 2021
From Benzinga
Moderna To Test New COVID-19 Vaccine Targeting South Africa Strain
February 25, 2021
From Benzinga
Chihuahua
February 24, 2021
From Blogs - TalkMarkets
AstraZeneca is aiming to meet EU second-quarter COVID-19 vaccine targets, despite reports
February 24, 2021
From MarketWatch
Global COVID cases fall for a sixth straight week as hopes for J&J vaccine are bolstered by FDA data
February 24, 2021
From MarketWatch
Gold Gains on Powell’s Dovish Statements
February 24, 2021
From Blogs - TalkMarkets
Terrible Tuesday
February 23, 2021
From Blogs - TalkMarkets
Why You Should Keep Your Distance from Ocugen Stock
February 23, 2021
From InvestorPlace
U.S. death toll atop 500,433 as Biden calls for unity, face masks and vaccination ‘when it’s your turn’
February 23, 2021
From MarketWatch
From Benzinga
Airlines and travel stocks surge as U.K. sets out lockdown exit plans
February 23, 2021
From MarketWatch
Why AstraZeneca Is Voluntarily Withdrawing Imfinzi In US For Advanced Bladder Cancer Indication
February 22, 2021
From Benzinga
U.S. edges closer to half a million COVID deaths as experts look to FDA meeting on J&J’s one-dose vaccine
February 22, 2021
From MarketWatch
Will we still be wearing masks in 2022? When will life return to normal? Dr. Fauci cautions, ‘It really depends on what you mean by normality’
February 22, 2021
From MarketWatch
From Benzinga
From Benzinga
It's Already Doubled in 2021, and This Healthcare Juggernaut Is Just Getting Started
February 20, 2021
From Motley Fool
Will AstraZeneca's Pain Be Johnson & Johnson's Gain?
February 20, 2021
From Motley Fool
Forget Ocugen! Here's a COVID Stock That Could Make You Richer Quicker
February 19, 2021
From Motley Fool
NVAX Stock Is the Most Undervalued Vaccine Maker for Endemic Covid-19
February 18, 2021
From InvestorPlace
Pfizer Says South African Variant Could Significantly Reduce Vaccine Protection: Reuters
February 18, 2021
From Benzinga
3 Markedly Better Stocks to Buy Than Sundial or AMC
February 18, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.